Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Gaertner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Der Radiologe|March 20, 2009
[PET-CT for neuroendocrine tumors and nuclear medicine therapy options]K Scheidhauer, M Miederer, F C Gaertner
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 19, 2010
Molecular imaging of avb3 expression in cancer patientsF C Gaertner, M Schwaiger, A J Beer
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 20, 2010
Molecular imaging of αvß3 expression in cancer patientsF C Gaertner, M Schwaiger, A J Beer
Current Pharmaceutical Biotechnology|January 5, 2012
Imaging of hypoxia using PET and MRIF C Gaertner, M Souvatzoglou, G Brix, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2012
Radiolabelled RGD peptides for imaging and therapyF C Gaertner, H Kessler, H-J Wester, et al.
HNO|April 29, 2017
[PET-CT in head and neck cancer]T Send, B Kreppel, F C Gaertner, et al.
Archives of Orthopaedic and Trauma Surgery|October 1, 2024
Diagnosis of periprosthetic loosening of total hip and knee arthroplasty using <sup>68</sup>Gallium-Zoledronate PET/CTA Touet, S Koob, S Kürpig, et al.
Nuclear Medicine and Biology|September 15, 2019
Clinical evaluation of [<sup>68</sup>Ga]Ga-DATA-TOC in comparison to [<sup>68</sup>Ga]Ga-DOTA-TOC in patients with neuroendocrine tumoursF C Gaertner, T Plum, B Kreppel, et al.
Trials|March 6, 2023
DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trialP Krausewitz, R A Bundschuh, F C Gaertner, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Der Radiologe|March 20, 2009
[PET-CT for neuroendocrine tumors and nuclear medicine therapy options]K Scheidhauer, M Miederer, F C Gaertner
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 19, 2010
Molecular imaging of avb3 expression in cancer patientsF C Gaertner, M Schwaiger, A J Beer
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 20, 2010
Molecular imaging of αvß3 expression in cancer patientsF C Gaertner, M Schwaiger, A J Beer
Current Pharmaceutical Biotechnology|January 5, 2012
Imaging of hypoxia using PET and MRIF C Gaertner, M Souvatzoglou, G Brix, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2012
Radiolabelled RGD peptides for imaging and therapyF C Gaertner, H Kessler, H-J Wester, et al.
HNO|April 29, 2017
[PET-CT in head and neck cancer]T Send, B Kreppel, F C Gaertner, et al.
Archives of Orthopaedic and Trauma Surgery|October 1, 2024
Diagnosis of periprosthetic loosening of total hip and knee arthroplasty using <sup>68</sup>Gallium-Zoledronate PET/CTA Touet, S Koob, S Kürpig, et al.
Nuclear Medicine and Biology|September 15, 2019
Clinical evaluation of [<sup>68</sup>Ga]Ga-DATA-TOC in comparison to [<sup>68</sup>Ga]Ga-DOTA-TOC in patients with neuroendocrine tumoursF C Gaertner, T Plum, B Kreppel, et al.
Trials|March 6, 2023
DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trialP Krausewitz, R A Bundschuh, F C Gaertner, et al.
Pageof 1